We are live on ! Find out more
DCM

DGS Capital Management Portfolio holdings

AUM $609M
1-Year Est. Return 44.78%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+44.78%
3 Year Est. Return
+177%
5 Year Est. Return
10 Year Est. Return
AUM
$550M
AUM Growth
+$65.5M
Cap. Flow
+$34.4M
Cap. Flow %
6.25%
Top 10 Hldgs %
40.03%
Holding
460
New
97
Increased
207
Reduced
131
Closed
20

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$2.66M
2
CLS icon
Celestica
CLS
+$1.28M
3
NVO
Novo Nordisk
NVO
+$568K
4
SKM icon
SK Telecom
SKM
+$424K
5
FICO icon
Fair Isaac
FICO
+$326K

Sector Composition

Rank Sector Weight
1 Financials 26.33%
2 Technology 25.43%
3 Communication Services 8.51%
4 Consumer Discretionary 6.05%
5 Healthcare 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
251
McKesson
MCK
$101B
$346K 0.06%
+448
New +$316K
ING icon
252
ING
ING
$102B
$346K 0.06%
13,253
+1,107
+9% +$26.7K
R icon
253
Ryder
R
$10.1B
$344K 0.06%
1,824
+458
+34% +$82.6K
TRMB icon
254
Trimble
TRMB
$13.9B
$342K 0.06%
+4,186
New +$341K
PEP icon
255
PepsiCo
PEP
$190B
$340K 0.06%
2,421
+239
+11% +$34.1K
VO icon
256
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$340K 0.06%
4,624
-484
-9% -$34.8K
CCEP icon
257
Coca-Cola Europacific Partners
CCEP
$47.9B
$338K 0.06%
3,735
-96
-3% -$8.91K
HLF icon
258
Herbalife
HLF
$1.29B
$337K 0.06%
39,916
+5,341
+15% +$50.4K
ACN icon
259
Accenture
ACN
$108B
$335K 0.06%
1,358
-584
-30% -$152K
VRTX icon
260
Vertex Pharmaceuticals
VRTX
$126B
$334K 0.06%
854
+350
+69% +$146K
IBN icon
261
ICICI Bank
IBN
$108B
$329K 0.06%
10,893
+768
+8% +$25.1K
L icon
262
Loews
L
$23.6B
$328K 0.06%
+3,267
New +$309K
MC icon
263
Moelis & Co
MC
$4.94B
$327K 0.06%
4,583
+147
+3% +$10.5K
T icon
264
AT&T
T
$163B
$325K 0.06%
+11,524
New +$327K
MTD icon
265
Mettler-Toledo International
MTD
$28.6B
$325K 0.06%
+265
New +$332K
FLEX icon
266
Flex
FLEX
$44.8B
$325K 0.06%
5,609
+674
+14% +$35.8K
NOBL icon
267
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
$323K 0.06%
6,274
-348
-5% -$18K
GRMN
268
Garmin
GRMN
$60B
$321K 0.06%
+1,304
New +$301K
FDX icon
269
FedEx
FDX
$75.4B
$319K 0.06%
1,354
+382
+39% +$88.1K
PDBC icon
270
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.3B
$319K 0.06%
23,739
+156
+0.7% +$2.07K
AMD icon
271
Advanced Micro Devices
AMD
$789B
$318K 0.06%
1,968
-370
-16% -$59.7K
TM icon
272
Toyota
TM
$225B
$318K 0.06%
1,665
-76
-4% -$14.3K
RTX icon
273
RTX Corp
RTX
$301B
$316K 0.06%
1,889
+114
+6% +$17.7K
IMPP icon
274
Imperial Petroleum
IMPP
$208M
$316K 0.06%
66,051
-1,502
-2% -$5.28K
FOX icon
275
Fox Class B
FOX
$23.9B
$315K 0.06%
+5,498
New +$290K

Similar funds

DGS Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, DGS Capital Management held 460 positions worth $550M, up 14% from $484M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

DGS Capital Management deployed $34.4M of net new capital in Q3 2025, opening 97 new positions and adding to 207 existing holdings. Its largest new stake was iShares Ethereum Trust ETF: 16,283 shares worth $513K.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Palantir, an estimated $2.66M trimmed.

  • DGS Capital Management's largest Q3 2025 buy was iShares Ethereum Trust ETF: 16,283 shares worth $513K.
  • DGS Capital Management added most to Microsoft in Q3 2025, an estimated $1.64M increase.
  • DGS Capital Management's biggest Q3 2025 reduction was Palantir, cutting an estimated $2.66M.
  • DGS Capital Management fully exited Allison Transmission in Q3 2025, selling an estimated $294K.
  • DGS Capital Management's ten largest holdings make up 40% of its $550M portfolio in Q3 2025.
  • DGS Capital Management opened 97 new positions and closed 20 in Q3 2025.
  • DGS Capital Management's portfolio value rose 14% quarter-over-quarter to $550M.

Based on DGS Capital Management's 13F filing for Q3 2025, filed 24 Feb 2026.